Inactive Instrument

All News Taro Pharmaceutical Industries Ltd. Other OTC

Equities

IL0010827181

End-of-day quote Other OTC Other stock markets
- ^USD	-

Jun. 25	Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index	CI
Jun. 24	Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index	Jun. 24	CI
Taro Pharmaceutical Industries : Sun Pharma Completes Taro Merger Form 6 K	Jun. 24	PU
Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	Jun. 23	CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical	May. 23	MT
Taro Shareholders Approve Merger with Sun Pharma	May. 23	PR
Taro Shareholders Approve Merger with Sun Pharma	May. 23	AQ
Taro Pharmaceutical Industries : Shareholders Approve Merger with Sun Pharma - Form 6-K	May. 23	PU
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call	May. 22
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call	May. 22
Taro Pharmaceutical Industries : PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024 - Form 6-K	May. 21	PU
Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise	May. 20	MT
Taro: Fiscal Q4 Earnings Snapshot	May. 20	AQ
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M	May. 20	MT
Taro Provides Results for Year Ended March 31, 2024	May. 20	BU
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024	May. 20	CI
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 20	CI
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.	May. 20	PR
Taro to Release Full Year Results on May 20, 2024	May. 15	BU
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger	May. 09	AQ
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger	May. 08	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Taro Pharmaceutical Industries Ltd. Other OTC

Equities

IL0010827181

All News

Filters